Skip to main content
 

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member Company was granted an unique dual clearance from the FDA for the AI detection of
life-threatening cardiac conditions, including heart attacks.

Learn more here.

More News

  • AHA Innovators’ Network Member Noah Labs Closes Financing Round

  • Member company Accukardia selected as Quarterfinalist for 2023 Digital Health Hub Foundation Rising Star Award

  • AliveCor Featured in Business Insider’s most promising start ups of 2024